Calendar

Sep
24
Tue
2019
2019 Early Detection of Cancer Conference
Sep 24 – Sep 26 all-day
Oct
23
Wed
2019
Cancer Early Detection Seminar Series – Michael Shen, Ph.D.
Oct 23 @ 11:00 am – 12:00 pm
Cancer Early Detection Seminar Series - Michael Shen, Ph.D.

Cancer Early Detection Seminar

“Best Practices in Hip Imaging”

Michael Shen, PhD
Professor of Medicine, Genetics and Development, Urology and Systems Biology
Columbia University Medical Center

ABSTRACT
TBD

_____________________________________________
Hosted by
Sanjiv Sam Gambhir, MD, PhD<https://med.stanford.edu/profiles/sanjiv-gambhir>

Sponsored by
The Canary Center and the Stanford Cancer Institute
Stanford University

If you would like to be included on the email distribution list for weekly reminders, contact Ashley Williams (ashleylw.at.stanford.edu)

RSVP and more info at: https://www.onlineregistrationcenter.com/register/222/page1.asp?m=298&c=41

Jan
23
Thu
2020
Early Detection Seminar Series – Victoria Seewaldt, M.D. @ Beckman Center, Munzer Auditorium (B060)
Jan 23 @ 11:00 am – 12:00 pm
Early Detection Seminar Series - Victoria Seewaldt, M.D. @ Beckman Center, Munzer Auditorium (B060)

CEDSS: “Strategies to Identify Aggressive Breast Cancer Biology in Black and Latina Women”

Victoria Seewaldt, MD
Ruth Ziegler Professor and Chair, Department of Population Sciences
Associate Director for Population Sciences Research, Comprehensive Cancer Center
City of Hope

Beckman Center, Munzer Auditorium (B060)
11:00am – 12:00pm Seminar & Discussion
12:00pm – 12:15pm Reception & Light Refreshments
RSVP here: https://www.onlineregistrationcenter.com/VictoriaSeewaldt

ABSTRACT

Over 90% of breast cancer is cured; yet there remain highly aggressive breast cancers that develop rapidly and are extremely difficult to treat, much less prevent. Examples are triple-negative breast cancer in Black/African American women and luminal B breast cancers in Black/African Americans and Latinas. Breast cancers that rapidly develop between breast imaging are called “interval cancers”. Here we aim to investigate biologically aggressive precancerous breast lesions and their matched invasive breast cancers in women of diverse race and ethnicity. Our team has the unique ability to perform single cell in situ transcriptional profiling in combination with dynamic and spatial genomics/proteomics; this allows us to identify multi-dimensional spatial and temporal relationships that drive the transition from biologically aggressive pre-cancer to interval breast cancer.

 

ABOUT

Victoria Seewaldt, M.D., is an accomplished clinician and researcher who’s devoted to improving the lives of her patients and the community at large. She has led community outreach education efforts on cancer prevention through personal wellbeing and directed research aimed at finding biomarkers that can be used for early cancer detection, particularly triple-negative breast cancers that are especially resistant to treatment.

At City of Hope, Dr. Seewaldt will direct efforts to provide breast cancer education, free breast cancer screening and treatment, mentorship of young minority scholars, and a forum for community partnered trials. Clinically, Dr. Seewaldt aims to empower women at high breast cancer risk to be full partners in developing wellness strategies to promote personal health.

Dr. Seewaldt received her medical degree from the University of California, Davis, and completed her residency and clinical fellowship at the University of Washington in Seattle. She then pursued a medical oncology fellowship with the Fred Hutchinson Cancer Research Center and then became an assistant professor at Ohio State University. Afterwards, she transferred to Duke University, where she held various clinical, academic and leadership roles in its School of Medicine and Comprehensive Cancer Center — most recently as a professor, co-leader of the breast and ovarian cancer program and head of the cancer breast prevention program — before joining City of Hope.

Mar
19
Thu
2020
CANCELLED – Cancer Early Detection Seminar Series – Azra Raza, M.D. @ CANCELLED
Mar 19 @ 11:00 am – 12:30 pm
CANCELLED - Cancer Early Detection Seminar Series - Azra Raza, M.D. @ CANCELLED

Please note this seminar is now cancelled and will be rescheduled for a future date. Please contact Ashley Williams (ashleylw@stanford.edu) with any questions or concerns. Thank you for your understanding!

CEDSS: “The First Cell and the Human Cost of going after Cancer’s last”

Azra Raza, MD

Chan Soon-Shiong Professor of Medicine

Director, Myelodysplastic Syndrome Center

Columbia University Medical Center

May
26
Tue
2020
Cancer Early Detection Seminar Series – Eric Fung, M.D., Ph.D. @ Zoom - See Description for Zoom Link
May 26 @ 11:00 am – 12:00 pm
Cancer Early Detection Seminar Series - Eric Fung, M.D., Ph.D. @ Zoom - See Description for Zoom Link

CEDSS: “Multicancer detection of early-stage cancers with simultaneous tissue localization using a plasma cfDNA-based targeted methylation assay”

Eric Fung, M.D., Ph.D.

Senior Medical Director

GRAIL, Inc.

Please see zoom details below:
Meeting URL: https://stanford.zoom.us/j/230531527
Dial: +1 650 724 9799 (US, Canada, Caribbean Toll) or +1 833 302 1536 (US, Canada, Caribbean Toll Free)
Meeting ID: 230 531 527

ABOUT

Dr. Eric Fung is Vice President, Clinical Development at GRAIL, where he leads several clinical development programs in support of the development of a blood-based multi-cancer detection test. Dr. Fung has previously held clinical development and R&D leadership roles at Affymetrix, Vermillion, Ciphergen, and Roche Molecular Diagnostics. Dr. Fung has led clinical trials leading to FDA clearance of multiple IVD products. Dr. Fung received his MD, PhD from the Johns Hopkins University School of Medicine.

 

Hosted by: Sanjiv Sam Gambhir, M.D., Ph.D.
Spon
sored by the Canary Center & the Department of Radiology 
Stanford University – School of Medicine

Sep
9
Wed
2020
Diversity in Radiology & Molecular Imaging: What We Need to Know @ Virtual Event
Sep 9 – Sep 11 all-day
Diversity in Radiology & Molecular Imaging: What We Need to Know @ Virtual Event

Dear WMIS trainees, colleagues and friends,

We welcome you to join our upcoming virtual WMIS – Stanford Diversity conference on September 9-11, 2020. We are coming together to reinforce our commitment to diversity and to provide a forum for our team members to engage in meaningful discussions. The conference will provide keynote lectures, scientific presentations and educational lectures from leaders and pioneers in the field, who will discuss important topics related to racial justice, women in STEM and Global Health. We are also offering breakout sessions whereby carefully selected individuals will facilitate a discussion about how to implement more supportive and inclusive practices into our daily professional and personal life. The breakout sessions are designed to enable active involvement of smaller groups where people feel safe to discuss current challenges in the STEM field and actionable solutions.

This conference is free of charge and will provide 9.5 CME credits. Abstracts of all conference presentations and a summary of discussion points and insights provided by all conference participants will be published in Molecular Imaging & Biology. The organizing committee will provide 10 trainee prizes in the form of free WMIS memberships to conference attendants for the 2021 WMIC in Miami.

Website: https://www.wmislive.org

Oct
15
Thu
2020
Cancer Early Detection Seminar Series – Paul Boutros, Ph.D., M.B.A. @ Zoom - See Description for Zoom Link
Oct 15 @ 11:00 am – 12:00 pm
Cancer Early Detection Seminar Series - Paul Boutros, Ph.D., M.B.A. @ Zoom - See Description for Zoom Link

CEDSS: “The Origins and Detection of Lethal Prostate Cancer”

Paul Boutros, Ph.D., M.B.A.
Director, Cancer Data Sciences
UCLA

Please see zoom details below:
Meeting URL: https://stanford.zoom.us/s/93515779500
Dial: +1 650 724 9799 or +1 833 302 1536
Meeting ID: 935 1577 9500
Meeting Passcode: 767148

ABOUT
Boutros earned his B.Sc. degree from the University of Waterloo in Chemistry in 2004, and his Ph.D. degree from the University of Toronto, Canada, in Medical Biophysics in 2008. At Toronto, he also earned an executive M.B.A. from the Rothman School of Management. In 2008, Boutros started his independent research career at the Ontario Institute for Cancer Research first as a fellow (2008–2010) and then as principal investigator (2010–2018). He moved to California to join the UCLA faculty in 2018.

 

Hosted by: Utkan Demirci, Ph.D.
Spon
sored by the Canary Center & the Department of Radiology 
Stanford University – School of Medicine

Jan
15
Fri
2021
Radiology-Wide Research Meeting @ Zoom - See description for more information
Jan 15 @ 12:00 pm – 1:00 pm
Radiology-Wide Research Meeting @ Zoom - See description for more information

Radiology Department-Wide Research Meeting

Curt Langlotz, MD, PhD: Overview of the AIMI Center
Brian Hargreaves, PhD: Research Details from Town Hall, Q&A, and COVID19 Updates

 

Location: Zoom – Details can be found here: https://radresearch.stanford.edu
Meetings will be the 3rd Friday of each month.

 

Hosted by: Brian Hargreaves, PhD
Sponsored by: the the Department of Radiology

Jan
19
Tue
2021
Cancer Early Detection Seminar Series – Thomas Kislinger, Ph.D. @ Zoom - See Description for Zoom Link
Jan 19 @ 11:00 am – 12:00 pm
Cancer Early Detection Seminar Series - Thomas Kislinger, Ph.D. @ Zoom - See Description for Zoom Link

CEDSS: Systematic identification of fluid-based biomarkers for ovarian and prostate cancer

 

Thomas Kislinger, Ph.D.
Professor & Chair
Department of Medical Biophysics
University of Toronto

Senior Scientist
Princess Margaret Cancer Centre

 

Zoom Webinar Details 
Meeting URL: https://stanford.zoom.us/s/94878578384
Dial: +1 650 724 9799 or +1 833 302 1536
Webinar ID: 948 7857 8384
Passcode: 692692
Register Here

 

ABOUT

Thomas Kislinger received his MSc in Analytical Chemistry from the University of Munich, Germany (1998). He completed his PhD in 2001, investigating the role of Advanced Glycation Endproducts in diabetic vascular complications at the University of Erlangen, Germany and Columbia University, New York. Between 2002 and 2006 he completed a post-doctoral fellowship at the University of Toronto. In 2006 he joined the Princess Margaret Cancer Centre as an independent investigator. Dr. Kislinger holds positions as Senior Scientist at the Princess Margaret Cancer Centre and as Professor and Chair at the University of Toronto in the Department of Medical Biophysics. The Kislinger lab applies proteomics technologies to translational and basic cancer biology. This includes the development of novel proteomics methodologies, identification of liquid biopsy signatures and the molecular identification of novel cell surface markers.

 

Hosted by: Utkan Demirci, Ph.D.
Spon
sored by: The Canary Center & the Department of Radiology 
Stanford University – School of Medicine

Feb
19
Fri
2021
Radiology-Wide Research Meeting @ Zoom - See description for more information
Feb 19 @ 12:00 pm – 1:00 pm
Radiology-Wide Research Meeting @ Zoom - See description for more information

Radiology Department-Wide Research Meeting

Location: Zoom – Details can be found here: https://radresearch.stanford.edu
Meetings will be the 3rd Friday of each month.

 

February 19 Speakers: 

Bruce Daniel, MDCenter Overview: IMMERS

Jennifer McNab, PhDEncoding and Decoding Diffusion MRI

 

Hosted by: Brian Hargreaves, PhD
Sponsored by: the the Department of Radiology